Regulus Therapeutics reverse splits shares 1:12

|About: Regulus Therapeutics (RGLS)|By:, SA News Editor

Aimed at regaining compliance with Nasdaq's minimum bid price requirement, Regulus Therapeutics (NASDAQ:RGLS) executed a 1:12 reverse stock split after the close yesterday. Post-split trading commences today.

Subscribe for full text news in your inbox